These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6157470

  • 1. Multiple ventricular extrasystoles following administration of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA).
    Falkson G.
    Cancer Treat Rep; 1980; 64(2-3):358. PubMed ID: 6157470
    [No Abstract] [Full Text] [Related]

  • 2. Acute ventricular fibrillation and death during infusion of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA).
    Von Hoff DD, Elson D, Polk G, Coltman C.
    Cancer Treat Rep; 1980; 64(2-3):356-8. PubMed ID: 6931630
    [No Abstract] [Full Text] [Related]

  • 3. A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
    Currie VE, Howard J, Wittes R.
    Cancer Clin Trials; 1981; 4(3):249-51. PubMed ID: 6895189
    [Abstract] [Full Text] [Related]

  • 4. Neurologic and cardiac rhythm abnormalities associated with 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) therapy.
    Legha SS, Latreille J, McCredie KB, Bodey GP.
    Cancer Treat Rep; 1979; 63(11-12):2001-3. PubMed ID: 526933
    [No Abstract] [Full Text] [Related]

  • 5. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.
    Carroll DS, Kemeny N, Lynch G, Wookcock T.
    Cancer Treat Rep; 1980; 64(10-11):1149-50. PubMed ID: 6893951
    [No Abstract] [Full Text] [Related]

  • 6. Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma.
    Sordillo PP, Magill GB, Gralla RJ, Golbey RB.
    Cancer Treat Rep; 1980; 64(10-11):1129-30. PubMed ID: 6893950
    [No Abstract] [Full Text] [Related]

  • 7. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
    Van Echo DA, Markus S, Aisner J, Wiernik PH.
    Cancer Treat Rep; 1980; 64(8-9):1009-10. PubMed ID: 6893810
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ventricular fibrillation following AMSA. Uncomplicated retreatment following correction of hypokalemia.
    McLaughlin P, Salvador PG, Cabanillas F, Legha SS.
    Cancer; 1983 Aug 01; 52(3):557-8. PubMed ID: 6688037
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methanesulfon-m-anisidide) in patients with adenocarcinoma of the pancreas.
    Sternberg CN, Magill GB, Sordillo PP, Cheng E, Currie VE.
    Am J Clin Oncol; 1983 Aug 01; 6(4):459-62. PubMed ID: 6688151
    [Abstract] [Full Text] [Related]

  • 16. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma.
    Sordillo PP, Magill GB, Gralla RJ, Kelsen DP.
    Am J Clin Oncol; 1982 Jun 01; 5(3):273-5. PubMed ID: 6896259
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA) and 5-azacytidine (AZA) in the treatment of relapsed adult acute leukemia.
    Kahn SB, Sklaroff R, Lebedda J, Conroy JF, Bulova S, Brodsky I.
    Am J Clin Oncol; 1983 Aug 01; 6(4):493-502. PubMed ID: 6191561
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.